Follow
Laurent Rivory
Laurent Rivory
Unknown affiliation
Verified email at unsw.edu.au
Title
Cited by
Cited by
Year
Clinical pharmacokinetics of docetaxel
SJ Clarke, LP Rivory
Clinical pharmacokinetics 36, 99-114, 1999
5701999
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase
LP Rivory, MR Bowles, J Robert, SM Pond
Biochemical pharmacology 52 (7), 1103-1111, 1996
3031996
Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy
KA Slaviero, SJ Clarke, LP Rivory
The lancet oncology 4 (4), 224-232, 2003
2882003
Hepatic cytochrome P450 3A drug metabolism is reduced in cancer patients who have an acute-phase response
LP Rivory, KA Slaviero, SJ Clarke
British journal of cancer 87 (3), 277-280, 2002
2482002
Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions
MC Haaz, L Rivory, C Riche, L Vernillet, J Robert
Cancer research 58 (3), 468-472, 1998
2011998
The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance
DG Le Couteur, R Fraser, S Kilmer, LP Rivory, AJ McLean
Clinical pharmacokinetics 44, 187-200, 2005
1882005
Pharmacokinetic interrelationships of irinotecan (CPT-11) and its three major plasma metabolites in patients enrolled in phase I/II trials.
LP Rivory, MC Haaz, P Canal, F Lokiec, JP Armand, J Robert
Clinical cancer research: an official journal of the American Association …, 1997
1771997
Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype
H Gurney, M Wong, RL Balleine, LP Rivory, AJ McLachlan, JM Hoskins, ...
Clinical Pharmacology & Therapeutics 82 (1), 33-40, 2007
1742007
Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients
LP Rivory, JF Riou, MC Haaz, S Sable, M Vuilhorgne, A Commerçon, ...
Cancer Research 56 (16), 3689-3694, 1996
1641996
Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy
KA Slaviero, JA Read, SJ Clarke, LP Rivory
Nutrition and cancer 46 (2), 148-157, 2003
1612003
Identification and kinetics of a β-glucuronide metabolite of SN-38 in human plasma after administration of the camptothecin derivative irinotecan
LP Rivory, J Robert
Cancer chemotherapy and pharmacology 36, 176-179, 1995
1521995
Factors affecting cytochrome P-450 3A activity in cancer patients
SD Baker, RHN Van Schaik, LP Rivory, AJ Ten Tije, K Dinh, ...
Clinical cancer research 10 (24), 8341-8350, 2004
1502004
Kinetics of the in Vivo Interconversion of the Carboxylate and Lactone Forms of Irinotecan (CPT-11) and of Its Metabolite SN-38 in Patients
LP Rivory, E Chatelut, P Canal, A Mathieu-Boué, J Robert
Cancer research 54 (24), 6330-6333, 1994
1481994
Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38
HM Dodds, MC Haaz, JF Riou, J Robert, LP Rivory
Journal of Pharmacology and Experimental Therapeutics 286 (1), 578-583, 1998
1361998
Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients
R Sharma, JM Hoskins, LP Rivory, M Zucknick, R London, C Liddle, ...
Clinical cancer research 14 (3), 817-825, 2008
1332008
Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan …
LP Rivory, J Robert
Journal of Chromatography B: Biomedical Sciences and Applications 661 (1 …, 1994
1271994
Molecular, cellular, and clinical aspects of the pharmacology of 20 (S) camptothecin and its derivatives
LP Rivory, J Robert
Pharmacology & therapeutics 68 (2), 269-296, 1995
1111995
Transcriptional Repression of Hepatic Cytochrome P450 3A4 Gene in the Presence of Cancer
KA Charles, LP Rivory, SL Brown, C Liddle, SJ Clarke, GR Robertson
Clinical cancer research 12 (24), 7492-7497, 2006
872006
The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes Differential hydrolysis for the lactone and carboxylate forms: Differential …
MC Haaz, LP Rivory, C Riché, J Robert
Naunyn-Schmiedeberg's archives of pharmacology 356, 257-262, 1997
861997
Frequency of cytochrome P 450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance
LP Rivory, H Qin, SJ Clarke, J Eris, G Duggin, E Ray, RJ Trent, JF Bishop
European journal of clinical pharmacology 56, 395-398, 2000
822000
The system can't perform the operation now. Try again later.
Articles 1–20